BaLloon-based PFA Ablation poST Approval Outcomes for PAF and PersAF | stella

Learn About Find trials matched to me

About Learn Find trials matched to me →

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Privacy ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

BaLloon-based PFA Ablation poST Approval Outcomes for PAF and PersAF | stella

Back to Paroxysmal AF trials

Recruiting

This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.

Trial locations(22 sites)

Austria

Ordensklinikum Linz Elisabethinen, Linz

Belgium

AZ Sint Jan, Bruges

UZ Brussel, Brussels

Denmark

Rigshospitalet, Copenhagen

France

Hôpital Pitié Salpetrière, Paris

Key details

Sponsor

Abbott Medical Devices

Enrollment target

~300 participants

Started

December 2025

Primary completion

August 2027

Age range

18 Years and older

Last updated on clinicaltrials.gov in April 2026.

Contact the research team directly

Reach out to the team running this trial. Response times vary — some teams are faster than others.

Central contact

Karolilen Timmermans

Abbott Medical Devices

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Enrollment status is pulled from ClinicalTrials.gov and may not reflect real-time availability. If a trial appears full when you reach out, the team will let you know.

Your name

Email address

View full record on ClinicalTrials.gov

Follow this trial

Get notified in plain English when this trial's status changes. No account required.